LRPPRC anticorps (AA 611-907)
Aperçu rapide pour LRPPRC anticorps (AA 611-907) (ABIN1886578)
Antigène
Voir toutes LRPPRC AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 611-907
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 611 and 907 of LRP130
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- LRPPRC (Leucine-Rich PPR-Motif Containing (LRPPRC))
-
Autre désignation
- LRP130
-
Sujet
-
This gene encodes a protein that is leucine-rich and is thought to play a role in regulating the interaction of the cytoskeleton with a variety of cellular processes.Mutations in this gene are associated with the French-Canadian type of Leigh syndrome.Transcripts ranging in size from 4.8 to 7.0 kb which result from alternative polyadenylation have been reported for this gene.[provided by RefSeq]
-
Poids moléculaire
- 158 kDa
-
ID gène
- 10128
-
NCBI Accession
- NP_573566, NM_133259
Antigène
-